Start off with Qanatpharma

from Alexandra Papaelias

What a nice way to start off the year with Qanatpharma.  I always feel lucky to work with such a dedicated and bright team!

First offsite workshop of the year: Done ✅  Our international team gathered last week at the shores of the Ammersee in scenic Herrsching, Germany for an offsite workshop to map out what 2026 will look like for QP!

Together, we aligned near-term project tasks with QP’s long-term goals, mapped anticipated milestones for 2026 and beyond, and leaned into the kind of face-to-face collaboration that helps us move complex science forward.

A big thank you to our long-term collaborator Joerg. Schnabel for his insights on growing our patent portfolio and to Tobias Gabriel and Torsten Neuefeind from PROTEROS biostructures GmbH for joining us in a thoughtful discussion and ideation session about the progress of our NCE drug development targeting Hashtag#SubarachnoidHemorrhage, which was launched last year as a part of a research consortium with Zuse Institute Berlin and Enamine Ltd.

We were also excited to welcome Christoph Meinert, who is working alongside QP this year to lend his unique perspective on the opportunity for Hashtag#microvascular medicine to be the next critical domain in cardiovascular care.

In the photo from left to right: Christoph Meinert, Christian Albrecht, Steffen-Sebastian Bolz, Guenther Jucho, Alexandra Papaelias, Philipp Trepte